Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNg, Sing Hng
dc.description.abstractAlthough microfluidic technology is at its infancy stage, it offers many advantages for disease screening. In this thesis, our focus is to develop the supply chain strategies for serving the elusive pandemic demand in Singapore. To make the supply chain more robust, a few opportunities for delayed differentiation are identified. Next, demand-capacity evaluations for pandemic disease screening device were performed which suggests that the pandemic demand in Singapore is too low to warrant the establishment of a dedicated production facility. If a production facility is to be built, a possible business model could be to produce normal blood testing kits and reserved some capacity to satisfy the pandemic demand. Several production options are then discussed and that the production facility is advised to choose the option which can bring the highest expected profit.en_US
dc.format.extent76 p.en_US
dc.titleSupply chain network strategy for microfluidic-based clinical diagnostic deviceen_US
dc.contributor.supervisorAppa Iyer Sivakumaren_US
dc.contributor.schoolSchool of Mechanical and Aerospace Engineeringen_US​Master of Science (IMST)en_US
dc.contributor.researchSingapore-MIT Alliance Programmeen_US
item.fulltextWith Fulltext-
Appears in Collections:SMA Theses
Files in This Item:
File Description SizeFormat 
  Restricted Access
Main Report2.37 MBAdobe PDFView/Open

Page view(s)

Updated on Apr 14, 2021


Updated on Apr 14, 2021

Google ScholarTM


Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.